- Republican Wins Money Race in New York Special
- Congressional Hits and Misses: Week of April 20, 2015
- Pelosi Reacts to Death of Al Qaida Hostages
- Pelosi Calls Emerging Trade Deal a 'Pothole'
- Freshman's Campaign Issue Gets D.C. Attention
Its a scam of major proportions. When were trying to find billions of dollars to fund health care reform, this is an area that absolutely has to be cleaned up. Rep. Stephen Lynch (D-Mass.), June 24, Dow Jones NewswiresA recent Congressional hearing, led by Lynch, highlighted the absurdities of Americas broken drug payment system, as orchestrated by a handful of companies known as pharmacy benefit managers. While the hearing examined whether taxpayers and the federal employees health plan are getting ripped off, the broader lessons are unmistakable.As the long-standing goal of national health reform meets budget reality, applying common sense regulation to PBMs could save patients and employers billions of dollars and reduce the overhead of government-sponsored health care plans like Medicare and Medicaid.The sale of prescription drugs is tightly controlled by an ever-consolidating number of pharmacy benefit managers. They determine which drugs a plan covers and what the co-payments will be. These companies were originally hired by large employers and other health plan sponsors to rein in soaring drug costs. Instead, they have concocted a complex system that places their robust fees and profits above their clients interests, not to mention the patients.As a result, day can be night and black can be white. Patients are sometimes incentivized to buy name-brand drugs over cheaper generics once the PBM arranges for the drugmaker to pay it handsome kickbacks (euphemistically called rebates). Or patients are steered to purchase generic medicines from the PBMs own mail-order program even when a retail pharmacy can do it cheaper for the patient and the plan sponsor.In addition to the troublesome conflicts of interests, these secretive arrangements are now so prevalent as to represent a fatal flaw in todays drug market. Wave after wave of these hidden fees are costing employers, unions, the government and patients billions of dollars in higher insurance premiums.Quantifying exactly how high this PBM premium is can be difficult. Why? Employers, unions, governments and others that hire benefit managers are typically required to sign contracts banning them from looking behind the curtain, so to speak.In few other segments of our economy is such a lack of transparency tolerated. Imagine being asked to fork over a large sum for car repairs or a home renovation no questions asked and without an itemized bill. Any rational consumer would simply walk away.States have begun taking steps to address this problem, with 15 enacting new laws. And a coalition of more than 30 state attorneys general in the last five years filed lawsuits alleging PBM abuses, securing $370 million in restitution.